COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 1925: Articles 19241-19250  | Next

An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
Kitamura, N., Sacco, M. D., Ma, C., Hu, Y., Townsend, J., Meng, X., Zhang, F., Zhang, X., Kukuljac, A., Marty, M., Schultz, D., Cherry, S., Xiang, Y., Chen, Y., Wang, J.
10.1101/2020.12.19.423537 — Posted: 2020-12-20
Public adherence to governmental recommendations regarding quarantine and testing for COVID-19 in two Norwegian cohorts
Carlsen, E. O., Caspersen, I. H., Trogstad, L., Gjessing, H., Magnus, P.
10.1101/2020.12.18.20248405 — Posted: 2020-12-20
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
Harvey, R. A., Rassen, J. A., Kabelac, C. A., Turenne, W., Leonard, S., Klesh, R., Meyer, W. A., Kaufman, H. W., Anderson, S., Cohen, O., Petkov, V. I., Cronin, K. A., Van Dyke, A. L., Lowy, D. R., Sharpless, N. E., Penberthy, L. T.
10.1101/2020.12.18.20248336 — Posted: 2020-12-20 Discussion: Onsite | Offsite
The challenges of the coming mass vaccination and exit strategy in prevention and control of COVID-19, a modelling study
Tang, B., Liu, P., Yang, J., Wu, J., Xiao, Y., Tang, S.
10.1101/2020.12.18.20248478 — Posted: 2020-12-20
Classification of the infection status of COVID-19 in 186 countries
Odagaki, T., Suda, R.
10.1101/2020.12.17.20248445 — Posted: 2020-12-19
Fluoxetine pharmacokinetics and tissue distribution suggest a possible role in reducing SARS-CoV-2 titers
Eugene, A. R.
10.1101/2020.12.17.20248442 — Posted: 2020-12-19 Discussion: Onsite
Lessons learned from Vietnam's COVID-19 response: the role of adaptive behavior change and testing in epidemic control
Pham, Q. D., Stuart, R. M., Nguyen, T. V., Luong, Q. C., Tran, D. Q., Pham, T. Q., Phan, L. T., Dang, T. Q., Tran, D. N., Do, H. T., Mistry, D., Klein, D. J., Abeysuriya, R. G., Oron, A. P., Kerr, C. C.
10.1101/2020.12.18.20248454 — Posted: 2020-12-19
The COSEVAST Study: Unravelling the role of Arterial Stiffness in COVID-19 Disease severity.
Kumar, S., Kumar, N., Kumar, A., Bhushan, D., Kumar, A., Kumar, A., Singh, V., Singh, P. K.
10.1101/2020.12.18.20248317 — Posted: 2020-12-19
Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients
Stals, M. A., Grootenboers, M. J., van Guldener, C., Kaptein, F. H., Braken, S. J., Chen, Q., Chu, G., van Driel, E. M., Iglesias del Sol, A., de Jonge, E., Kant, K. M., Pals, F., Toorop, M. M., Cannegieter, S. C., Klok, F. A., Huisman, M. V., Dutch COVID and Thrombosis Coalition (DCTC)
10.1101/2020.12.18.20248265 — Posted: 2020-12-19
History of premorbid depression is a risk factor for COVID-related mortality: Analysis of a retrospective cohort of 1,387 COVID+ patients
Clouston, S., Luft, B. J., Sun, E.
10.1101/2020.12.17.20248362 — Posted: 2020-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).